Respiratory devices or equipment are commonly used in the medical settings as per the medical condition. Ventilators are the most common tools, which are commonly used in emergency medicine and long-term critical care. In addition to the therapeutic respiratory devices, the diagnostic and monitoring devices minimize hospitalizations, thereby lowering the cost associated with medical settings.
Download PDF Brochure of Research Report:
The major factor driving growth of the respiratory devices market include INCREASING prevalence of respiratory diseases such as COPD and asthma, increasing respiratory disease with rise in pollution level and rising geriatric population. According to the study by Global Burden of Disease, 2016, an estimated around 251 million cases of COPD were reported worldwide. According to the World Health Organization (WHO), 2015, an estimated 3.17 million deaths were caused by the disease accounting for 5% of all deaths. However, lack of awareness regarding the diseases harmful effects of certain respiratory care devices on neonates are the factors restraining respiratory devices market growth.
Increasing support from international organizations for prevention of chronic respiratory diseases is expected to accelerate the market growth
Various organizations, institutions, and agencies are working towards improving the diagnosis and the medical care needed to reduce the global burden of respiratory diseases. For instance, the Global Alliance against Chronic Respiratory Diseases (GARD) was formed with the support from the World Health Organization (WHO) to control chronic respiratory diseases. GARD is a voluntary alliance of national, international organizations, and agencies from many economies. The main objective of GARD is to develop simple and affordable strategies for chronic respiratory diseases (CRD) and to encourage economies to implement health promotion and CRD prevention policies. Also, increasing birth defects such as newborn respiratory distress syndrome, cyanosis, and Broncho-pulmonary dysplasia requires the need for neonate/pediatric respiratory devices to increase the survival chances of infants. According to the Centers of Disease Control and Prevention (CDC), an estimate of 1.5 million babies were born with birth defects with about one quarter primary consultations related to respiratory complaints.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]